Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sibutramine Pharmacodynamics on Gastric Function in Obesity
NCT00330525Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- Jan 2005
- Primary completion
- Mar 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sibutramine in obesity, Overweight, sponsored by Mayo Clinic. Started Jan 2005; status: completed.
02
Drugs
sibutramine
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on NCT00330525.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00330525.